Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention
Cureus · 02.03.2026
DOI: 10.7759/cureus.104567 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 02.03.2026. Verfasst von Nicolle Contreras Figueroa und 5 weiteren Autor:innen. Beteiligte Einrichtung: General Medicine, Caja Costarricense de Seguro Social (CCSS), San Jose, CRI. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Medicine, Caja Costarricense de Seguro Social (CCSS), San Jose, CRI.
- Anesthesiology and Perioperative Medicine, Hospital de las Mujeres Dr. Adolfo Carit Eva (HOMACE), San Jose, CRI.
- Gynecologic Oncology, Hospital de las Mujeres Dr. Adolfo Carit Eva (HOMACE), San Jose, CRI.
- Obstetrics and Gynecology, Hospital de las Mujeres Dr. Adolfo Carit Eva (HOMACE), San Jose, CRI.
- Emergency Medicine, Hospital Los Chiles, Los Chiles, CRI.
- General Medicine, Área de Salud Upala, Upala, CRI.
Zitieren
APA
Contreras Figueroa, N., Lopez Mendoza, M. J., Ulloa, A., Jiron Vindas, J., Salazar Estrada, M. A., & Valle Mena, M. J. (2026). Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention. Cureus. https://doi.org/10.7759/cureus.104567
Vancouver
Contreras Figueroa N, Lopez Mendoza MJ, Ulloa A, Jiron Vindas J, Salazar Estrada MA, Valle Mena MJ. Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention. Cureus. 2026. doi:10.7759/cureus.104567
BibTeX
@article{ContrerasFigueroa2026,
author = {Contreras Figueroa, Nicolle and Lopez Mendoza, Maynor Jose and Ulloa, Asdrubal and Jiron Vindas, Jeilyn and Salazar Estrada, Maria Antonieta and Valle Mena, María Jennifer},
title = {Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.104567}
}
EUVIMED